Core Insights - The "zero tariff" policy for pharmaceuticals and medical devices in Hainan Free Trade Port has been operational for one year, with significant benefits being realized [1] - As of December 31, 2025, the total value of imported "zero tariff" medical products reached approximately 460 million yuan, resulting in tax reductions of about 62 million yuan [1] Group 1: Policy Implementation - The "zero tariff" policy allows registered medical institutions, higher medical education institutions, and medical research institutes in the Boao Lecheng International Medical Tourism Pilot Zone to import specified pharmaceuticals and medical devices without import duties, VAT, and consumption tax [1] - This policy aims to lower operational costs for medical institutions and significantly reduce the financial burden on patients [1] Group 2: Industry Impact - The policy has been described as a "bonus" for registered medical institutions, facilitating easier cash flow for companies and reducing costs for patients [1] - The Haikou Customs has actively optimized customs clearance processes and conducted in-depth research to address the challenges faced by different types of enterprises in accessing the benefits of the policy [1]

Group 1 - The core viewpoint of the article emphasizes the importance of Nanjing's selection as a pilot project for public hospital reform and high-quality development by 2025, aiming to meet the health needs of the people [1] - The city will strictly follow national and provincial policies, implementing the municipal government's opinions and requirements for advancing the pilot project [1] - The goal is to establish Nanjing as a health hub in the Yangtze River Delta, seizing opportunities and fostering innovation to ensure the effective implementation of the pilot project [1] Group 2 - Nanjing will adopt a high-level coordination approach, learning from the Sanming medical reform experience to promote overall reform and enhance service collaboration [2] - The focus will shift from disease treatment to prioritizing people's health, demonstrating the integration of the "three medical" systems [2] - The city aims to enhance medical service capabilities by addressing complex and severe cases, creating a medical service structure that includes peak medical institutions and grassroots networks [2] - There will be an emphasis on building an integrated healthcare service system, promoting tightly-knit urban medical groups and county-level medical communities [2] - The city plans to strengthen party leadership, reform personnel and salary systems, and adjust medical service prices dynamically to ensure sustainable operations [2] - Nanjing will promote information sharing and develop a comprehensive health network, integrating new technologies with health services to provide more precise and convenient healthcare for the public [2]

Investment Rating - The report maintains a "Buy" rating for the medical services industry [5][66]. Core Insights - The medical and biological sector experienced a decline of 2.06% this week, ranking 28th among 31 primary industries [1][11]. - The AI pharmaceutical company Insilico Medicine was listed on the Hong Kong Stock Exchange, raising HKD 2.277 billion, marking it as the highest fundraising biotech IPO in 2025 [4][63]. - AI technology is significantly reducing the time and costs associated with drug discovery and clinical trials, with potential savings of approximately USD 26 billion annually in compound screening and clinical trial costs [5][65]. Summary by Sections Industry Performance - The medical services sector's PE (ttm) is 31.28X, with a PB (lf) of 3.17X, showing a decrease of 0.52X in PE and 0.05X in PB from the previous week [3][30]. - The medical services II sub-industry index closed at 6363.18 points, down 1.40% [22][23]. Company Performance - Top-performing companies in the medical services sector include: - Purui Eye Hospital (+5.3%) - Sanbo Brain Science (+4.7%) - Puris (+3.0%) - Tigermed (+2.9%) - Baicheng Pharmaceutical (+2.2%) - Underperforming companies include: - Bid Pharmaceutical (-6.6%) - Sunshine Nuohua (-6.1%) - Zhaoyan New Drug (-5.2%) - International Medicine (-4.0%) - Kanglong Chemical (-3.5%) [2][28]. Investment Recommendations - The report suggests focusing on high-growth areas such as ADC CDMO and peptide CDMO in the pharmaceutical outsourcing services, with companies like WuXi AppTec, Haoyuan Pharmaceutical, and WuXi Biologics being highlighted [9][66]. - It also recommends looking at third-party medical testing laboratories and consumer healthcare sectors, particularly in ophthalmology and dentistry, with companies like Aier Eye Hospital and Dean Diagnostics [9][66].

Core Viewpoint - The book "Jin Yamei: A Zhejiang Woman Going Global" by Lou Weining highlights the life and contributions of Jin Yamei (also known as Jin Yunmei), the first female medical doctor in China, emphasizing her role in modernizing and facilitating cultural exchanges between China and the West [2][26]. Group 1: Author and Book Overview - The author, Lou Weining, is an English teacher who has dedicated years to translating and interpreting Jin Yamei's life, incorporating materials from the American Soybean Research Center [2]. - The book features a bilingual format, which may aid Chinese readers in understanding the content better [2]. Group 2: Jin Yamei's Background and Education - Jin Yamei, orphaned at a young age, was adopted by missionaries and had various names in different documents due to the lack of a formal Chinese name [4]. - She graduated first in her class from the Women's Medical College of the New York Infirmary in 1885, becoming the first Chinese woman to earn a medical doctorate [10][12]. Group 3: Professional Journey and Challenges - After her graduation, Jin Yamei faced challenges in obtaining a medical license in the U.S., which was complicated by the administrative disarray in Hawaii at the time [11]. - She worked as a missionary doctor in Xiamen and later established a private practice in Kobe, Japan, where she faced health issues due to the local environment [11][10]. Group 4: Advocacy and Public Speaking - Jin Yamei transitioned from clinical practice to public speaking, addressing cultural differences and the realities faced by Chinese immigrants in America [15][19]. - She conducted a series of lectures across major U.S. cities, discussing various topics including science, history, and Eastern culture, which helped raise awareness of the Chinese community's struggles [16][19]. Group 5: Legacy and Impact - Jin Yamei's life and work symbolize the emergence of modern Chinese women and their contributions to society, particularly in the fields of medicine and cultural exchange [26]. - The book serves as a valuable resource for understanding the development paths of female elites who ventured beyond the Chinese cultural sphere during the late Qing period [26].

1月2日，工人在位于上海的中建三局一公司灿瑞科技全球芯片研发中心项目工地施工。 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社记者 丁汀 摄 1月2日，工作人员在中国邮政集团有限公司商丘市分公司邮件处理中心搬运快递。 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社发（李恒摄） 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社发（贾敏杰摄） 1月2日，工人在位于上海的中建三局一公司灿瑞科技全球芯片研发中心项目工地施工。 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社记者 丁汀 摄 1月2日，工人在位于上海的中建三局一公司灿瑞科技全球芯片研发中心项目工地施工。 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社记者 丁汀 摄 1月2日，在位于湖南省永州市新田县龙泉街道石甑源村的桂（东）新（田）高速建设工地，工人们进行防护坡施工作业（无人机照片）。 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社发（刘贵雄摄） 元旦假期期间，许多行业的劳动者依然坚守岗位，在工作中度过假期。 新华社 ...

工人医院泌尿外科是河北省级临床重点专科，在学科带头人曹凤宏教授的带领下，一直以来秉承对肿瘤 诊疗规范化、精准化、全程化的理念，为广大前列腺癌患者提供筛查、靶向穿刺活检、微创根治手术、 个性化诊疗方案、患教和随访等全程管理服务，以多学科MDT对各期前列腺癌患者开展规范化治疗， 努力提高前列腺癌的早期诊断、早期治疗，实现全程管理，为唐山地区、河北省前列腺癌全程化诊疗建 设贡献了学科力量。 （来源：唐山劳动日报） 本报讯 （龚仁）由中国抗癌协会男性生殖系统肿瘤专业委员会、中国临床肿瘤学会前列腺癌专家委员 会联合举办的中国前列腺癌全程化诊疗提升项目启动会2025年12月12日在上海举行。会上，唐山市工人 医院入选"中国前列腺癌全程化诊疗建设中心"，系省内首家、唐山地区唯一成为该中心成员单位的医 院。这也是对工人医院在前列腺肿瘤规范化、精准化、全程化治疗成果的充分肯定。 中国前列腺癌全程化诊疗提升项目由中国抗癌协会男性生殖系统肿瘤专业委员会、中国临床肿瘤学会前 列腺癌专家委员会共同发起，旨在持续推进中国前列腺癌全程规范化诊疗，提高前列腺癌领域内医生整 体诊疗水平，最终实现前列腺癌患者生存率和生活质量的有效提升。 ...

Group 1 - The Jiangsu Provincial Cancer Hospital has registered a "perioperative anesthesia and analgesia dataset" and is the first provincial tertiary hospital in Jiangsu to monetize data assets [1] - The collaboration involves the Jiangsu Provincial Cancer Hospital, the government, and enterprises, with the Xuanwu District Intellectual Property Bureau facilitating the process and Jiangsu Chuan Gu Technology providing technical support [1] - The hospital's medical data has been transformed into a product with intellectual property rights, allowing healthcare professionals to incorporate data transfer results into the research transformation system [1] Group 2 - The completion of intellectual property registration is just the beginning; the hospital aims to generate value from the data [2] - The hospital has established a "Medical Data Technology Transformation Joint Laboratory" with Xuanwu District to promote the application of "AI + healthcare" and explore the integration of tumor prevention and health data [2] - The Xuanwu District Intellectual Property Bureau plans to deepen cooperation with the hospital and focus on data annotation, which is crucial for artificial intelligence and model training [2]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Hai Ji Ya Medical (06078.HK) by 617,200 shares on January 2, with a total net reduction of 4,525,200 shares over the past five trading days [1] - Over the last 20 trading days, there have been 11 days of net reductions by southbound funds, totaling 1,763,000 shares [1] - As of now, southbound funds hold 208 million shares of Hai Ji Ya Medical, which represents 33.64% of the company's total issued ordinary shares [1] Group 2 - Hai Ji Ya Medical Holdings Limited is primarily an investment holding company that provides medical services [1] - The company operates through two business segments, with the hospital business segment focusing on comprehensive cancer diagnosis and treatment services, including radiation therapy, chemotherapy, surgery, and targeted therapy [1] - The other business segment is engaged in various other operations, with the company primarily conducting its business in the domestic market [1]

郑州大学第一附属医院医生在河南省武陟县乔庙镇为儿童进行诊疗。 近日，由河南省青年联合会组织开展的健康义诊活动走进焦作市武陟县乔庙镇，为当地群众进行常见 病、多发病、慢性病的筛查诊断和健康指导，让群众在家门口享受优质医疗服务。新华社发（冯小敏 摄） （来源：工人日报） ...

Core Viewpoint - The article highlights the efforts of Changshan County Traditional Chinese Medicine Hospital in building a clean and transparent medical environment through a comprehensive "Five Elements System" aimed at enhancing risk control and promoting integrity in healthcare practices [1] Group 1: Strengthening Responsibility and Supervision - The hospital's Party Committee emphasizes the importance of clean hospital construction as a political task, ensuring transparency in major decisions and financial matters [2] - The hospital's Discipline Inspection Commission focuses on regular supervision of key areas such as medical procurement and financial management, with strict penalties for violations [2] - Department heads are held accountable for maintaining integrity within their teams, with medical staff adhering to ethical standards and returning improper benefits to patients [2] Group 2: Enhancing Supervision Mechanisms - The hospital has improved its internal audit system to monitor financial activities and ensure compliance in major procurement and construction projects [3] - A whistleblower system has been established to encourage reporting of misconduct, with confidentiality and rewards for informants [3] - The hospital collaborates closely with health and insurance departments to prevent fraud and ensure compliance with regulations [3] Group 3: Institutional Safeguards - The hospital has established transparent procurement processes for medical supplies, ensuring fair competition and quality assessment [4] - Human resource management practices have been standardized to prevent nepotism and ensure the recruitment of qualified professionals [4] - Financial management systems have been strengthened to control costs and enhance both economic and social benefits [4] Group 4: Promoting Integrity Education - The hospital is committed to regular integrity training for staff, including lectures from experts and case studies to enhance awareness of ethical practices [6] - New employees receive pre-employment training focused on integrity to instill ethical values from the start of their careers [6] - Regular discussions on integrity are held for key positions to reinforce the importance of ethical behavior [6] Group 5: Cultivating a Culture of Integrity - The hospital promotes a clean culture through various communication channels, creating an environment that encourages integrity [7] - A "Cultural Corridor" has been established to educate staff on anti-corruption through visual displays [7] - Staff visits to integrity education bases are organized to strengthen their commitment to ethical practices [7]